Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies

Perrine Parize (1, 2) , Philippe Poujol (3, 4) , Pascale Morineau Le Houssine (5) , Julia Goesch (3, 4) , Cora Lucet (3, 4) , Laura Basuyau (3, 4) , Johann Cailhol (3, 4) , Laurent Dacheux (1, 2) , Hervé Bourhy (1, 2) , Paul-Henri Consigny (3, 4)

1 Lyssavirus, épidémiologie et neuropathologie - Lyssavirus Epidemiology and Neuropathology
2 CNR - Centre National de Référence de la Rage - National Reference Center Rabies
3 Centre d'infectiologie Necker-Pasteur [CHU Necker]
4 CMIP - Centre Médical de l'Institut Pasteur
5 Service des maladies infectieuses et tropicales

BackgroundThis study sought to determine the proportion of individuals with non-HIV secondary immunodeficiencies presenting inadequate antibody titers after rabies post-exposure prophylaxis (PEP) and to identify variables associated with inadequate response.MethodsA retrospective review of the records of immunocompromised patients having received a full course of PEP after a rabies exposure and having been tested for post-PPE antibody titers in two French Antirabies Clinics, between 2013 and 2018, was conducted. Antibody titers < 0.5 EU/ml (ELISA) were classified as inadequate.ResultsA total of 28 individuals were included, 6 had inadequate post-PPE titers. None of the tested variable was independently associated with inadequate titers.ConclusionsInadequate response was unpredictable and not explained either by the characteristics of patients or by the PEP regimen they received. These findings support the WHO recommendation to systematically assess post-PEP response in immunocompromised patients to detect non-responders, who might require an additional dose.

Domaines: Sciences du Vivant [q-bio]

Perrine Parize, Philippe Poujol, Pascale Morineau Le Houssine, Julia Goesch, Cora Lucet, et al.. Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies. Vaccine, 2020, 38 (33), pp.5091 - 5094. ⟨10.1016/j.vaccine.2020.06.037⟩. ⟨hal-03490462⟩